On [**2197-9-12**] he underwent right nephrectomy revealing renal cell carcinoma, clear cell type 6 cm, stage PT3AN0.
On [**2199-3-5**], he underwent left lower lobe wedge resection with pathology from an 8 mm nodule consistent with metastatic renal cell carcinoma noted.
Treatment options were discussed and high-dose IL-2 therapy was recommended.
He passed eligibility testing and began cycle 1 week 1 high-dose IL-2 on [**2199-7-1**] receiving 11 of 14 doses.
PAST MEDICAL HISTORY:  Kidney cancer as above, anxiety, hypercholesterolemia, right knee surgery, hypertension.
Celexa 20 mg per oral daily.
Fish oil 1000 mg per oral daily.
Aspirin 81 mg per oral daily.
Amlodipine 2.5 mg per oral daily.
Simvastatin 5 mg per oral daily.
Niacin 125 mg per oral daily.
Lorazepam 1 mg as needed.
Atarax 10 mg as needed pruritus.
Omeprazole 20 mg daily as needed for indigestion.
Albumin 4.1.
HOSPITAL COURSE:  The patient was admitted to begin therapy and underwent central line placement.
He was initiated on dopamine blood pressure support.
He was transitioned off dopamine and changed to Neo-Synephrine but had a persistent rapid ventricular response and persistent hypotension noted.
He was felt to require transfer to the ICU to provide further blood pressure support and rate slowing agents.
He transferred to the ICU and was initially treated with diltiazem without response and persistent hypotension.
He was subsequently placed on amiodarone with improvement in his heart rate and eventual conversion to normal sinus rhythm.
He was slowly weaned off Neo-Synephrine and transferred back to the floor on [**2199-7-26**].
IL-2 therapy was held at that time and blood pressure remained stable throughout the rest of his hospitalization.
Metabolic acidosis was noted with a minimum bicarb of 12 and improved with bicarb repletion up to 19.
He was anemic without need for packed red blood cell transfusion.
DISCHARGE DIAGNOSES:  Metastatic renal cell carcinoma status post cycle 1 week 2 __________ therapy complicated by shock, atrial fibrillation and acute renal failure.
Acetaminophen 325 to 650 mg q.i.d.
Cephalexin 500 mg twice a day times 5 days.
Citalopram 20 mg per oral daily.
Lasix 20 mg per oral times 5 days or until you reach pre-     treatment weight.
Hydroxyzine 50 mg q.i.d.
Imodium 2-4 mg q.i.d.
Lorazepam 0.5-1 mg 3 times daily as needed for nausea     and vomiting.
11.Eucerin cream topically.
